Literature DB >> 25187171

Prolonged fever and splenic lesions caused by Malassezia restricta in an immunocompromised patient.

Annabelle de St Maurice1, Haydar Frangoul, Alice Coogan, John V Williams.   

Abstract

Malassezia species are commonly found on human skin as commensals but can cause invasive infections in premature infants and immunocompromised hosts. Due to their fastidious growth, diagnosis of Malassezia infections can prove challenging. Molecular techniques can aid in diagnosis and treatment of invasive infections. We describe the case of a pediatric oncology patient with splenic lesions secondary to Malassezia restricta.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  hepatosplenic candidiasis; immunodeficiency; malassezia

Mesh：

Substances：

Year:  2014        PMID： 25187171      PMCID： PMC4644127          DOI： 10.1111/petr.12351

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN： 1397-3142


  17 in total

1.  Detection by CT scan of Penicillium sp. lesions in a patient with B-precursor acute lymphoblastic leukemia.

Authors:  Mary Y Mancao; Maria S Figarola; Felicia M Wilson; Elizabeth A Manci
Journal:  Pediatr Radiol       Date:  2002-03-23

Review 2.  Cutaneous mucormycosis with subsequent visceral dissemination in a child with neutropenia: a case report and review of the pediatric literature.

Authors:  F Wirth; R Perry; A Eskenazi; R Schwalbe; G Kao
Journal:  J Am Acad Dermatol       Date:  1997-02       Impact factor: 11.527

Review 3.  Hepatosplenic abscess caused by Curvularia boedijn in a patient with acute monocytic leukemia.

Authors:  M Shigemori; K Kawakami; T Kitahara; O Ijichi; M Mizota; N Ikarimoto; K Miyata
Journal:  Pediatr Infect Dis J       Date:  1996-12       Impact factor: 2.129

4.  Molecular differentiation of seven Malassezia species.

Authors:  A K Gupta; Y Kohli; R C Summerbell
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine.

Authors:  A K Gupta; Y Kohli; A Li; J Faergemann; R C Summerbell
Journal:  Br J Dermatol       Date:  2000-04       Impact factor: 9.302

6.  Fungal splenic abscess.

Authors:  J D Johnson; M J Raff
Journal:  Arch Intern Med       Date:  1984-10

Review 7.  Malassezia furfur--disseminated infection in premature infants.

Authors:  Y H Shek; M C Tucker; A L Viciana; H J Manz; D H Connor
Journal:  Am J Clin Pathol       Date:  1989-11       Impact factor: 2.493

8.  Systemic Malassezia furfur infections in patients receiving intralipid therapy.

Authors:  R W Redline; S S Redline; B Boxerbaum; B B Dahms
Journal:  Hum Pathol       Date:  1985-08       Impact factor: 3.466

9.  Management of splenic abscess in immunocompromised children.

Authors:  M D Smith; M Nio; J E Camel; J K Sato; J B Atkinson
Journal:  J Pediatr Surg       Date:  1993-06       Impact factor: 2.545

10.  Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest.

Authors:  Aristea Velegraki; Evangelos C Alexopoulos; Stavroula Kritikou; George Gaitanis
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948
View more
  2 in total

Review 1.  [Cutaneous Malassezia infections and Malassezia associated dermatoses: An update].

Authors:  P Nenoff; C Krüger; P Mayser
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

2.  Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identifying Clinical Malassezia Isolates.

Authors:  Julie Denis; Marie Machouart; Florent Morio; Marcela Sabou; Catherine Kauffmann-LaCroix; Nelly Contet-Audonneau; Ermanno Candolfi; Valérie Letscher-Bru
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.